Product Information
JENTADUETO 2.5 MG-850 MG TAB is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $8.4543 per EA under NDC 00597014718. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jan 30, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5; 850 mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597014718
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LINAGLIPTIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA201281FDA Approved
1/30/2012
TE Code
AB
On Market Since
2/13/2012
Pharmacological Classes
Price Statistics
The NADAC for JENTADUETO 2.5 MG-850 MG TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 105.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.4543 per EA |
|---|---|
| All-time high | $8.4543 (Sep 30, 2026) |
| All-time low | $4.1104 (Nov 28, 2013) |
| 52-week high | $8.4543 |
| 52-week low | $8.4261 |
| Median price | $7.3988 |
| Average price | $7.0515 |
| Largest weekly change | +11.8% (Jan 15, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
linagliptin and metformin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Biguanide class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of JENTADUETO 2.5 MG-850 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for JENTADUETO 2.5 MG-850 MG TAB, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $8.4543 per EA (NDC 00597014718), effective Sep 30, 2026.
How has the price of JENTADUETO 2.5 MG-850 MG TAB changed over time?
Over the history we have for it, the NADAC for JENTADUETO 2.5 MG-850 MG TAB has risen 105.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for JENTADUETO 2.5 MG-850 MG TAB?
Since Nov 28, 2013, the NADAC for JENTADUETO 2.5 MG-850 MG TAB has ranged from a low of $4.1104 (Nov 28, 2013) to a high of $8.4543 (Sep 30, 2026), with a median of $7.3988 per EA.
Are there cheaper alternatives to JENTADUETO 2.5 MG-850 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as JENTADUETO 2.5 MG-850 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures JENTADUETO 2.5 MG-850 MG TAB?
JENTADUETO 2.5 MG-850 MG TAB (NDC 00597014718) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.